Patrick Migambi

Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis

L. Rigouts, B. D. de Jong, A. Van Deun, 2020, The American journal of tropical medicine and hygiene.

Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.

L. Rigouts, C. Meehan, D. Affolabi, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

L. Rigouts, Cécile Uwizeye, B. D. de Jong, 2022, Journal of clinical tuberculosis and other mycobacterial diseases.

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.

L. Rigouts, W. B. de Rijk, B. D. de Jong, 2020, The Lancet. Microbe.

Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control

V. Ndahindwa, E. Klinkenberg, N. Kalisvaart, 2020, PloS one.